Screener / Plasma-Derived Medicines / Grifols SA

GRF · BME Spanish Ex

Grifols SA

Compliant

Under AAOIFI Standard 21, Grifols SA is compliant. Its core business is permissible and its interest-bearing debt is below 30% of market cap.

TickerGRF
ExchangeBME Spanish Ex
SectorPlasma-Derived Medicines

Full ratios for Grifols SA (impure revenue, debt and interest-bearing deposits under all four standards) are being added. Until then this page shows the screening verdict only. See the methodology for how each test works. Purindex publishes this screening to help people understand what they own. It does not recommend buying, selling or holding Grifols SA or any other security.